Posted in | News

Wienerberger Posts Recommended Cash Offer Document for Baggeridge

Wienerberger AG (Vienna, Austria) is posting the details of its bid to the shareholders of Baggeridge Brick PLC for the acquisition of the British company. After the UK competition commission cleared the transaction, Wienerberger offered the shareholders of Baggeridge a cash offer of 220.00 pence per share.

The increased offer reflects the full commitment of the Board of Wienerberger for the acquisition. Wienerberger has also received irrevocable undertakings to accept the offer for more than 32% of Baggeridge shares from all the members of the Baggeridge Board of Directors as well as the trustees of the P.A. Ward family trust, P.A. Ward and other shareholders. These undertakings will remain binding even in the event that a higher competing offer is made. This offer follows the initial offer announced in August 2006 with a price of 216.00 pence per share less the 4.35 pence dividend that was paid on 20 February 2007. The acceptance of this offer by shareholders is possible up to and including 6 June 2007. In order for the offer to take effect, Wienerberger must receive acceptances of more than 50% of the shares in Baggeridge.

"We are convinced that the merger of Baggeridge with Wienerberger will provide numerous advantages for both companies. We see ourselves as a strategic partner who places a strong focus on the rapid integration and further development of the Baggeridge business,” commented Wolfgang Reithofer, CEO of Wienerberger AG, on the offer. “This acquisition will create excellent opportunities for further profitable growth and also strengthen our presence on the British and Irish markets."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.